Novel Combinational Therapy Targets Pseudomonas aeruginosa Biofilm
Infections in a Flow Model
Jessica Geyer, Dr. Jayne Robinson
Results

Introduction
The rise of multidrug resistant (MDR) pathogens is
one of the greatest medical concerns of the century
because the use of antibiotics in these infections is
almost entirely useless, leaving patients at a higher
risk of mortality. In addition, almost 80% of human
infections involve biofilms which can be up to 1000fold more resistant to antibiotics than planktonic
cells, such as the biofilm-associated cells of
Pseudomonas aeruginosa. The resistance of these
pathogens has initiated an urgent need to look for
alternative antimicrobial therapies such as phage
therapy. In Phage therapy, lytic bacteriophages
eliminate bacteria that cause infection, even those
caused my MDR pathogens. Our lab has examined a
successful combinational therapy that treats biofilms
of P. aeruginosa using a lytic bacteriophage (PEV2)
and our novel patented porphyrin (ZnPor).

Figure 1: Phage subjected to ZnPor (25µM) in the presence of light
(300W) showed complete and immediate viricidal activity. Phage
subjected to ZnPor (25µM) without the presence of light still
showed a significant decrease from the control. (** > 2 log
difference of respective control, ***> 3 log difference of respective
control)

Figure 2: Planktonic PAO1 is completely lysed by PEV2 (MOI
10:1) at 4 hours. (** > 2 log difference respective of control,
***> 3 log difference respective of control)
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Figure 5: Confocal laser scanning microscopy of biofilms on selected
substrata imaged using a LIVE/DEAD stain. Green=LIVE, Red=DEAD,
Blue=ZnPor localization, Purple=overlap of ZnPor and Dead stains
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Significance
The significance of our novel approach of antimicrobial
management is that, unlike other protocols involving
biofilm eradication, our strategy addresses the issue of
resistance.
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Figure 3: Biofilms grown and subjected to a combination
treatment consisting of ZnPor (25µM) and phage PEV2 (MOI
10:1) then treated for 20 mins with and without light. on (A)
Polyethylene (Found in catheters and other plastics) (B) Titanium
(Found in biomedical implants) (C) Hydroxyapatite substrata
(Alternative to bone)

Figure 4: Phage quantifications after combination
treatment residing on coupons of (A) Polyethylene (B)
Titanium (C) Hydroxyapatite substrata (significance
determined by comparison to relative control)
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• While ZnPor retains significant dark
toxicity, photoactivation of ZnPor has
complete viricidal activity.
• Obligately lytic bacteriophage PEV2 has
significant bactericidal activity against
Pseudomonas aeruginosa.
• There is a significant synergistic effect
against P. aeruginosa biofilms when ZnPor
is used in combination with PEV2 that can
be seen quantitatively & qualitatively
(confocal laser scanning microscopy).
• The significance of the combination
therapy is increased when photoactivated.
• Phage PEV2 can be eliminated from the
system when in the presence of ZnPor and
can be completely eradicated off of
Titanium and Hydroxyapatite when ZnPor
is photoactivated.

